Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
Clinical profile and short-term outcomes of optic neuritis patients in India.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Multiple sclerosis: Brain volume loss strengthens disease measure.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
Multiple sclerosis: Infertility treatment increases multiple sclerosis activity.
Multiple Sclerosis: White and Gray Matter Damage Associated with Balance Deficit Detected at Static Posturography.
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes.
Danish translation and psychometric testing of the Rivermead Mobility Index.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Conventional and Advanced Imaging in Neuromyelitis Optica.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
Is There Extra Cost of Institutional Care for MS Patients?
Pages
« first
‹ previous
…
290
291
292
293
294
295
296
297
298
…
next ›
last »